CD24 and neoplasm: This integrated approach underscores the need for comprehensive studies to confirm the benefits and safety of these combination treatments, including the assessment of potential drug toxicities and side effects, as well as the exploration of combining radiotherapy with CD24 targeting to stimulate a more effective tumor immune environment response.